BIO Asia–Taiwan 2022 亞洲生技大會

BIO Asia–Taiwan 2022 亞洲生技大會

講師

Hong-Nerng, Ho

Session 13 – Advances in Cell & Gene Therapy

Date:29 July (Friday)
Time:  12:20 – 13:50 (GMT+8)

Hong-Nerng, Ho

General Consultant
​Taipei Medical University

MD, National Taiwan University Medical Collage. (1979)
Research Associate, University of Pittsburgh. (1984-1987)
Visiting Scholar, UCLA. (1991-1992)
Professor, National Taiwan University, Medical college. Department of Obstetrics and Gynecology, Graduate Institute of Immunology. (1998-2019)
Superintendent, National Taiwan University Hospital. (2015-2019)
Professor Emeritus, National Taiwan University. (2019-)
Chair Professor, Taipei Medical University. (2019-)
Chairman, Research Center for Cell Therapy and Regeneration Medicine, Taipei Medical University. (2020-)
Major in Reproductive Medicine, Immunology and Stem Cell Research.

Speech title & Synopsis

TMU Research Center for Cell Therapy and Regeneration Medicine

Taipei Medical University research center for cell therapy and regeneration medicine has been established Since 2015 . The main proposes of this center are to organize associated education, research, clinical trials and industrial developments in this University. It includes a GTP laboratory with several related core facilities, two master and PhD programs and three cell therapy center at three affiliated hospitals. Currently, there are iPSC, platelet lysate, armed T cells and tumor organoid etc. preclinical programs. Clinical trials such as MSC for cerebral palsy, Covid-19, ARDS, COPD, chronic renal failure and neurodegeneration disease. CAR-T has been conducted for one leukemia treatment with success. CIK and NK cell therapy and regeneration therapy including chondrocyte for knee join and fibroblast for skin defect have been provided for clinical service. Future works will seek the collaboration with the industrial partners.